Clinical characteristic | Value |
Age (years) | 69.8 (58.8–76.8) |
Men (n, %) | 148 (85.5) |
BMI (kg/m2) | 29.1 (25.4–32.7) |
Neck size (cm) | 40.0 (38.0–43.0) |
Waist/hip ratio | 1.02 (0.98–1.06) |
Diabetes (n, %) | 44 (25) |
COPD/asthma (n, %) | 34 (20) |
Ischaemic cardiomyopathy (n, %) | 89 (51) |
β blocker therapy (n, %) | 126 (73) |
ACEI/ARB therapy (n, %) | 157 (91) |
Atrial fibrillation (n, %) | 52 (30) |
Cardiac pacing (n, %) | 50 (29) |
NYHA classification (I/II/III/IV) | 24/110/37/2 |
BNP (pg/ml) | 118 (55–239) |
Left ventricular ejection fraction (%) | 40 (28–58) |
Data are presented as median (IQR), or number (%) of patients.
ACEI/ARB, ACE inhibitor or angiotensin receptor blocker; BMI, body mass index; BNP, B-type natriuretic peptide; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association.